(5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one

Catalog No. :
ACYMWB385
CAS No. :
865659-51-4
Molecular Formula :
C16H17N3O4S
Molecular Weight :
347.40

IUPAC Name:(E)-5-(benzo[d][1,3]dioxol-5-ylmethylene)-3-(morpholinomethyl)-2-thioxoimidazolidin-4-one

(5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one
IUPAC Name(E)-5-(benzo[d][1,3]dioxol-5-ylmethylene)-3-(morpholinomethyl)-2-thioxoimidazolidin-4-one
MDL No.MFCD04125230
Molecular FormulaC16H17N3O4S
Molecular Weight347.40
SMILESO=C(/C(N1)=C\C2=CC=C(OCO3)C3=C2)N(CN4CCOCC4)C1=S
InChI KeyGTOBXPCPDPTULD-KPKJPENVSA-N
Synonym5-(1,3-BENZODIOXOL-5-YLMETHYLENE)-3-(MORPHOLINOMETHYL)-2-THIOXOTETRAHYDRO-4H-IMIDAZOL-4-ONE;(5E)-5-[(2H-1,3-benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one;4-Imidazolidinone, 5-(1,3-benzodioxol-5-ylmethylene)-3-(4-morpholinylmethyl)-2-thioxo-
CAS No.865659-51-4

Synthetic Route by SureRoute

1. ACYMWB385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMWB385 route product structure diagram
    ACYMWB385865659-51-4
Inquiry

2. ACYMWB385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMWB385 route product structure diagram
    ACYMWB385865659-51-4
Inquiry

Comments (0)